| Pfizer files for EU approval of kidney cancer drug - Reuters |
|
|
Reuters The company is looking for European approval to treat patients with advanced renal cell carcinoma after failure of prior systemic treatment. Axitinib is an oral drug and inhibits certain receptors that can influence tumor growth and progression of |